Wall Street analysts predict that Amdocs Limited (NASDAQ:DOX) will post earnings per share of $0.89 for the current quarter, Zacks reports. Five analysts have provided estimates for Amdocs Limited’s earnings, with the lowest EPS estimate coming in at $0.86 and the highest estimate coming in at $0.91. Amdocs Limited reported earnings per share of $0.83 during the same quarter last year, which suggests a positive year-over-year growth rate of 7.2%. The firm is expected to report its next earnings report on Tuesday, November 14th.

According to Zacks, analysts expect that Amdocs Limited will report full year earnings of $3.53 per share for the current fiscal year, with EPS estimates ranging from $3.51 to $3.55. For the next financial year, analysts forecast that the business will report earnings of $3.78 per share, with EPS estimates ranging from $3.72 to $3.81. Zacks’ EPS calculations are a mean average based on a survey of sell-side analysts that follow Amdocs Limited.

Amdocs Limited (NASDAQ:DOX) last posted its quarterly earnings data on Wednesday, August 2nd. The technology company reported $1.02 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.06. The firm had revenue of $967 million during the quarter, compared to analysts’ expectations of $967.04 million. Amdocs Limited had a net margin of 11.11% and a return on equity of 14.73%. The company’s quarterly revenue was up 4.0% compared to the same quarter last year. During the same quarter last year, the company posted $0.90 EPS.

Several research firms have recently issued reports on DOX. Barclays PLC reaffirmed a “hold” rating and issued a $68.00 price objective on shares of Amdocs Limited in a research note on Friday. Stifel Nicolaus reaffirmed a “buy” rating and issued a $72.00 price objective (up previously from $68.00) on shares of Amdocs Limited in a research note on Thursday. Zacks Investment Research raised Amdocs Limited from a “hold” rating to a “buy” rating and set a $75.00 price objective for the company in a research note on Friday. BidaskClub raised Amdocs Limited from a “sell” rating to a “hold” rating in a research note on Tuesday, August 1st. Finally, J P Morgan Chase & Co reaffirmed a “neutral” rating and issued a $68.00 price objective on shares of Amdocs Limited in a research note on Tuesday, May 9th. Five equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $67.63.

ILLEGAL ACTIVITY NOTICE: This piece of content was posted by American Banking News and is owned by of American Banking News. If you are accessing this piece of content on another publication, it was illegally stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/08/07/amdocs-limited-nasdaqdox-expected-to-announce-earnings-of-0-89-per-share.html.

A number of hedge funds have recently added to or reduced their stakes in DOX. FMR LLC increased its stake in Amdocs Limited by 12.8% in the first quarter. FMR LLC now owns 12,620,266 shares of the technology company’s stock worth $769,710,000 after buying an additional 1,435,539 shares in the last quarter. BlackRock Inc. increased its stake in Amdocs Limited by 1,661.3% in the first quarter. BlackRock Inc. now owns 8,715,991 shares of the technology company’s stock worth $531,590,000 after buying an additional 8,221,139 shares in the last quarter. Boston Partners increased its stake in Amdocs Limited by 9.7% in the first quarter. Boston Partners now owns 7,464,464 shares of the technology company’s stock worth $455,257,000 after buying an additional 661,397 shares in the last quarter. Janus Capital Management LLC increased its stake in Amdocs Limited by 9.7% in the first quarter. Janus Capital Management LLC now owns 6,759,428 shares of the technology company’s stock worth $412,250,000 after buying an additional 599,865 shares in the last quarter. Finally, OppenheimerFunds Inc. increased its stake in Amdocs Limited by 8.2% in the first quarter. OppenheimerFunds Inc. now owns 4,451,655 shares of the technology company’s stock worth $271,507,000 after buying an additional 337,655 shares in the last quarter. 89.97% of the stock is owned by institutional investors and hedge funds.

Shares of Amdocs Limited (DOX) opened at 66.27 on Monday. Amdocs Limited has a 52-week low of $54.91 and a 52-week high of $67.62. The firm has a market cap of $9.67 billion, a PE ratio of 23.03 and a beta of 0.54. The firm has a 50-day moving average of $65.23 and a 200 day moving average of $62.44.

The company also recently announced a quarterly dividend, which will be paid on Friday, October 20th. Shareholders of record on Friday, September 29th will be given a dividend of $0.22 per share. This represents a $0.88 dividend on an annualized basis and a yield of 1.33%. The ex-dividend date is Thursday, September 28th. Amdocs Limited’s dividend payout ratio is presently 30.66%.

About Amdocs Limited

Amdocs Limited is a provider of software and services for communications, entertainment and media industry service providers. The Company develops, implements and manages software and services associated with business support systems (BSS), operational support systems (OSS) and network operations to enable service providers to introduce new products and services, process orders, monetize data, support new business models and enhance their understanding of their customers.

Get a free copy of the Zacks research report on Amdocs Limited (DOX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Amdocs Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs Limited and related companies with MarketBeat.com's FREE daily email newsletter.